CS Paper Radar

"I Know Where to Look," But Does the LLM? Charting the Gaps Between Clinical Expert Needs and Unstructured Data Abstraction Tools

Venkatesh Sivaraman, Rigney Turnham, George Bonano, Nevin Aresh, Renumathy Dhanasekaran, Margaret Guo, Sindhu Kubendran, Olivia Lin, Jonathan D Louie, Kristan Olazo, Jeanne Shen, Harish Vasudevan, Jeanette Wong, Emily Alsentzer, Jason A Fries, Anobel Odisho, John Gordan, Jean Feng, Julian C Hong

cs.HC q-bio.OT ·submitted 2026-09-16 18:33 UTC · v1

Abstract

Clinical data abstraction, the process of distilling structured information from patient records, plays a key role in advancing knowledge about diseases such as cancer. Information extraction (IE) with large language models (LLMs) could accelerate this process, but it is unclear whether current frameworks effectively support clinical researchers without AI expertise. To address this, we co-designed an interactive LLM-based abstraction system called Libretto with seven cancer research teams, then evaluated the system's ability to help them answer real-world research questions. We found that while clinicians knew where and how to annotate complex concepts in patient notes, in twelve of fourteen tasks they faced barriers to replicating those intuitions with LLMs. Contextual note reliability judgments, difficulties in steering vibe-coded prompts, and inflexible evaluation strategies necessitated fundamental changes to the IE workflow. Our results highlight open problems for HCI research to bridge the gaps between AI data work tools and clinical users' needs.

Comment
Under review

Closest papers

Nearest neighbours by meaning across the whole index.

From Analytics to Tumor Boards: An Evidence-Linked Multi-Agent Workflow for Oncology Feature Extraction

cs.AI ·2026-08-29 ·Daniel Kang, Michelle Hu, Soorya Ram Shimgekar, Shayan Vassef, Yufan Wang +10 more
similarity 0.73
Abstract

Clinically relevant oncology information is distributed across heterogeneous, longitudinal documentation, creating substantial abstraction burden and requiring accurate attribution across specimens, tumors, biomarkers, and time points, while manual cancer-registry abstraction can require 27.2 minutes per case, highlighting the need for scalable methods that preserve clinical context while converting documentation into structured data. We evaluate an oncology information-extraction workflow in which OncoLens supplies multi-source, oncology-aware document selection, aggregation, and normalization from integrated EHRs, while the NimbleMind Multi-Agent System (nMAS) is a configurable oncology information-extraction workflow that extracts clinically relevant structured fields from fragmented oncology documentation. The extraction task uses a clinician-informed schema of 328 attributes spanning report metadata, diagnosis, staging, and cancer-type-specific information. nMAS separates clinician-defined field specifications from model execution and combines complexity-aware extraction, report-level consolidation, and source-grounded validation. The retrospective evaluation included 230 de-identified oncology documents from 40 patients and 418 clinician-reviewed document-field pairs containing 1,126 non-empty reference values. Evaluation focused on fields identified by clinicians as present in the source documents rather than exhaustively annotating all 328 schema fields. nMAS achieved a rank-weighted value-level precision of 82.6%, recall of 87.5%, and F1 of 85.0%, compared with an F1 of 66.4% for an independently implemented UMA-style MiniMax M2.5 comparator. These findings support the feasibility of using a configurable, source-grounded extraction workflow to convert fragmented oncology documentation into reusable structured data.

0.27

RAG-Enhanced LLMs for Interactive Explainability in Clinical Decision Support Systems

cs.AI cs.HCcs.LG ·2026-11-06 ·Lorenzo Mannocci, Francesca Naretto, Lucia Passaro, Anna Monreale
published similarity 0.72
Abstract · Published in HC_AIxIA_HYDRA 2025, Communications in Computer and Information Science, vol. 2830, pp. 50-63, Springer, 2026. Please cite the …

Artificial Intelligence (AI) is increasingly embedded in high-risks decision-making systems across domains such as healthcare, finance, and the judicial system. As reliance on predictive models grows, so does the demand for Explainable AI (XAI) to ensure transparency, trust, and interpretability. However, existing XAI approaches often fail to present explanations in a format accessible to domain experts, limiting their practical utility. Large Language Models (LLMs) have recently emerged as a bridge between complex models and end-users, offering natural language explanations. Yet, their use introduces new risks, including hallucinated outputs and lack of source traceability. To address these challenges, we propose a Clinical Decision Support System (CDSS) that not only combines standard predictive models with XAI techniques but also incorporates a Retrieval-Augmented Generation module as an interactive enhancer. This module grounds explanations in verified medical knowledge, reformulates technical outputs into a human-like format, and enables users-such as clinicians-to actively query the system. By fostering an interactive, human-in-the-loop environment, our approach empowers domain experts to explore model decisions, contextualize explanations, and build trust in AI-assisted diagnostics. The study concludes with preliminary experiments validating the proposed methodology.

0.20

CRISS: A Retrieval-Augmented AI Chatbot for Assisting Cancer Registrars

cs.AI cs.CL ·2026-09-24 ·Vani Seth, Mohammad Beheshti, Anirudh Kambhampati, Vishwa Bhayani, Lucinda Ham +2 more
similarity 0.72
Abstract · 21 pages, 13 figures, 7 tables. Keywords: cancer registry, retrieval-augmented generation, large language models, conversational AI, clinica…

Cancer registrars, including Oncology Data Specialists (ODSs), must interpret complex and frequently updated coding and staging standards. We developed CRISS (Cancer Registry Intelligent Support System), a retrieval-augmented generation (RAG) conversational assistant that provides rapid, citation-supported access to registry guidance. This study evaluated whether CRISS could (1) support accurate and citation-supported responses, (2) improve access to and interpretation of relevant guidance, and (3) support training/helpdesk use while preserving human oversight of final abstraction decisions. We built a domain-specific knowledge base from national cancer registry standards, segmented into metadata-tagged passages and indexed as dense embeddings. Retrieved passages were used to generate citation-grounded responses through a large language model (LLM). Open-weight, proprietary, and non-RAG baseline models across Gemini and GPT families were evaluated on easy, medium, and hard registry questions using an LLM-as-a-Judge protocols. RAG configurations consistently outperformed non-RAG approaches, especially as question difficulty increased. Mean grounding scores for RAG were 0.62/0.56/0.59 across easy/medium/hard tiers versus 0.29/0.26/0.29 for non-RAG. RAG models also achieved higher semantic-similarity scores overall. Proprietary RAG models performed strongest on easy and medium questions, while local RAG models ranked highest on hard questions and proprietary models were generally more cautious. Domain-specific RAG improved evidence grounding and response quality for cancer registry questions while enabling citation-supported assistance across complexity levels. CRISS demonstrates the potential of human-centered, citation-grounded AI to support cancer registrars while preserving human oversight for final coding decisions.

0.12

ClinAgent: A ReAct-Based Agent for Conversational Access to Clinical Trial Information

cs.AI cs.CLcs.IR ·2026-09-12 ·Antonino Vaccarella, Riccardo Cantini, Domenico Talia, Paolo Trunfio, Marianna Talia +2 more
published similarity 0.69
Abstract · Accepted at the CIBB 2026 conference (https://cibb2026.teralab.ai/)

Querying clinical trial registries remains a manual and error-prone process, requiring researchers to navigate large volumes of semi-structured data without support for natural language interaction or cross-source synthesis. To address this, we introduce ClinAgent, a conversational system based on agentic Retrieval-Augmented Generation (RAG) that enables clinicians and researchers to query clinical trial information in plain language and receive grounded, up-to-date responses across multi-turn interactions. The system centers on a Large Language Model (LLM) agent following the ReAct paradigm, which iteratively reasons over queries, selects among a set of integrated tools, and refines its actions based on intermediate outputs. These tools include a ClinicalTrials.gov search interface, a PubMed module, and a Python-based analyzer operating on a locally cached structured dataset of clinical trials. We evaluate the system using a three-phase framework assessing operational effectiveness, planning quality, tool-use efficiency, and expert qualitative judgments, comparing three LLM backends: Gemini 3.0 Flash and two variants of DeepSeek V3.2 (thinking and non-thinking). Results reveal complementary strengths, with DeepSeek (thinking mode) excelling in planning quality, while Gemini achieves the highest overall performance and strongest expert ratings. Overall, our findings highlight the potential of agentic AI systems to improve the accessibility and synthesis of clinical trial information, supporting more efficient and user-centered biomedical research workflows.

0.29

MedCaseAgent: From Multimodal Clinical Evidence to Rare Disease Case Reports

cs.AI ·2026-10-23 ·Hongkang Chu, Yifan Shen, Tianjiao Yu, Zhuoqing Zhong, Jianguo Cao +2 more
code/data similarity 0.69
Abstract

Although Large Language Models (LLMs) have demonstrated potential in clinical documentation, generating the rigorous, evidence-based reasoning required for unprecedented, atypical, and rare disease case reports remains a significant challenge. We present MedCaseAgent, an end-to-end agentic reasoning paradigm that bridges this gap by synthesizing publication-quality reports from unstructured clinical notes. MedCaseAgent leverages a hierarchical structure, integrating patient-level data mining with iterative, tool-integrated reasoning. By dynamically querying medical literature and knowledge bases, the agent maintains high clinical fidelity and assesses case novelty. The framework is inherently modular, supporting various backbone LLMs in a plug-and-play fashion. To facilitate this research, we release MedCase-150K, a large-scale multimodal clinical case-report corpus, and MedCase-Bench, a robust temporally held-out evaluation suite. We also introduce an open-source model post-trained from Qwen3.5-9B and optimized specifically for this task. Under both LLM-judged and rule-based evaluation, MedCaseAgent outperforms existing general-purpose and specialized medical LLMs and agents. Blinded expert reviews and ablations further support the system's clinical relevance and evidence grounding.

0.25

DiagTrace: An Interactive Benchmark for Clinical Decision Making

cs.CL cs.AI ·2026-11-16 ·Yufan Wang, Rui Yang, Yi Lin, Chunhua Weng, Yifan Peng
publishedbenchmark similarity 0.68
Abstract · Accepted to Findings of EACL 2027

Large language models (LLMs) have shown strong performance on medical question answering and diagnostic reasoning benchmarks. However, existing evaluations typically provide all patient information upfront and assess only the final diagnosis or rationale. This setup ignores the need to acquire diagnostic evidence incrementally from incomplete information in real-world diagnosis. To bridge this gap, we introduce DiagTrace, a source-grounded benchmark for evaluating whether LLMs can reconstruct the documented diagnostic trajectory through interactive information seeking. Each benchmark instance is built from a PubMed Central case report and includes an initial presentation, an event bank, a clinical course, and diagnostic references. DiagTrace contains 510 cases across eight specialties, with 225 used to evaluate four LLMs on clinical-course alignment, interaction quality, and efficiency. Results reveal trade-offs in coverage, source-consistent ordering, and turn use.

0.14

Knowledge Graph-Augmented Ambient AI for Clinical Note Generation

cs.CL cs.AI ·2026-09-04 ·Jakir Hossain, Yi-Fei Zhao, Hongjian Wang, Minmei Shih, Katie Leigh Mullen +7 more
similarity 0.68
Abstract

Ambient AI is increasingly adopted in healthcare to automatically generate clinical notes from patient-clinician conversations, with the potential to substantially reduce clinician documentation burden. However, generated notes may omit clinically relevant information discussed during the encounter, creating information gaps that can affect downstream care. Knowledge graphs (KGs) constructed from encounter transcripts can provide a structured representation of what was discussed and enable systematic identification of missing information from generated notes that are critical for patient care. In this study, we introduce Coverage-Directed Revision (CDR), a model-agnostic framework that constructs a KG from the encounter transcript, identifies medical concepts absent from an initially generated note, and directs large language models (LLMs) to restore the missing information without modifying the underlying note-generation system. We evaluate CDR on two datasets: 1) Pitt-Bench, a local dataset comprising rehabilitation sessions, and 2) ACI-Bench, a public dataset for benchmarking clinical note generation. We tested four underlying LLMs widely used in ambient AI systems. The results show that CDR consistently improves content recall across all evaluated conditions. Our study provides a practical approach for improving the completeness of ambient AI-generated clinical documentation.

0.16

Responsible Integration of AI in Cancer Genomics: Barriers, Risks, and Pathways to Trustworthy Clinical Translation

cs.AI cs.CL ·2026-08-31 ·Bahar İlgen, Yiannos Tolias, Denise Kühnert, Paraskevi Papadopoulou, Magnus Westerlund +3 more
similarity 0.67
Abstract · Review article

Artificial intelligence (AI) and natural language processing (NLP) are increasingly used to extract, integrate, and interpret biomedical knowledge relevant to cancer genomics, yet their translation into routine clinical oncology has been comparatively slow. The central challenge is not computational capability alone, but trustworthy integration into clinical workflows. This review examines how NLP and AI support the cancer genomics pipeline, from literature mining and automated variant interpretation to clinical trial matching, knowledge graph construction, and multimodal data integration. We identify four interrelated translational failure domains: evidence inconsistency, explainability and uncertainty, data governance and reproducibility, and interoperability. Rather than considering these challenges in isolation, we take a systems-level view, focusing on their interaction across the translational pathway. We propose a conceptual framework and roadmap for addressing these domains through rigorous validation, uncertainty-aware methods, interoperable infrastructures, regulatory alignment, and human oversight across the AI lifecycle. Progress toward routine clinical use will depend less on further improving model capability than on systematically addressing these interacting failure domains from development through deployment and post-deployment monitoring.

0.12